The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.
Levodopa has been studied across 19 research domains including 🧠 Neuroprotection, 🧠 Focus & Attention, 🌤️ Mood & Depression, ✨ Skin & Hair, ❤️ Cardiovascular. The primary research focus is 🧠 Neuroprotection with 71% of studies addressing this area.
The following compounds share molecular targets with Levodopa, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Levodopa is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.